Newland Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	120.07	173.63	158.98	132.3	114.98
Depreciation & Amortization	55.49	37.53	31.08	24.24	20.86
Other Amortization	2.05	2.54	1.54	0.16	-
Loss (Gain) From Sale of Assets	-	-	-0.07	0.44	0.21
Asset Writedown & Restructuring Costs	10.9	2.62	1.46	0.32	0.11
Loss (Gain) From Sale of Investments	-10.25	-13.95	-17.6	-1.52	-0.17
Provision & Write-off of Bad Debts	-	2.27	-3.6	2.23	11.14
Other Operating Activities	-0.67	5.05	-0.65	6.29	6.54
Change in Accounts Receivable	66.03	-82.3	117.51	-146.8	-99.16
Change in Inventory	-32.92	-18.25	21.6	25.05	-29.15
Change in Accounts Payable	-93.4	17.32	-54.7	28.45	20
Change in Other Net Operating Assets	-1.6	0.3	-0.48	5.28	3.9
Operating Cash Flow	116.94	126.76	259.46	82.85	49.08
Operating Cash Flow Growth	-7.75%	-51.14%	213.19%	68.80%	2.55%
Capital Expenditures	-101.38	-110.79	-96.51	-74.34	-25.4
Sale of Property, Plant & Equipment	0.06	0.14	0.54	0.04	0.06
Investment in Securities	-24.2	78.28	129.46	-691.5	-8.5
Other Investing Activities	10.25	-	-	0.33	0
Investing Cash Flow	-115.28	-32.36	33.48	-765.47	-33.83
Long-Term Debt Issued	-	-	-	89.09	118.46
Total Debt Issued	-	-	-	89.09	118.46
Long-Term Debt Repaid	-	-3.25	-2.75	-203.05	-100
Total Debt Repaid	-	-3.25	-2.75	-203.05	-100
Net Debt Issued (Repaid)	-	-3.25	-2.75	-113.96	18.46
Issuance of Common Stock	-	-	-	838.57	4
Common Dividends Paid	-112.02	-80.02	-66.68	-6.77	-36.7
Other Financing Activities	-1.8	-	-	-19.09	-6.94
Financing Cash Flow	-113.82	-83.26	-69.43	698.74	-21.19
Net Cash Flow	-112.16	11.14	223.51	16.12	-5.94
Free Cash Flow	15.55	15.97	162.94	8.5	23.68
Free Cash Flow Growth	-2.63%	-90.20%	1816.39%	-64.10%	-23.36%
Free Cash Flow Margin	2.31%	2.20%	25.01%	1.35%	4.61%
Free Cash Flow Per Share	0.04	0.04	0.42	0.03	0.08
Cash Income Tax Paid	38.58	53.72	43.59	66.68	43.77
Levered Free Cash Flow	31.14	29.72	158.98	-11.33	-12.63
Unlevered Free Cash Flow	31.14	29.78	159.06	-7.03	-8.43
Change in Working Capital	-60.64	-82.93	88.32	-81.62	-104.59

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.